During the past decade, Röpcke-Zweers Ziekenhuis conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Röpcke-Zweers Ziekenhuis" #1 sponsor was "Celgene" with 1 trials, followed by "Comprehensive Cancer Centre The Netherlands" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Maastricht University Medical Center" with 1 trials sponsored and "Milestone Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Röpcke-Zweers Ziekenhuis" #1 collaborator was "ALMANAC Trialists Group" with 1 trials as a collaborator, "Borstkanker Onderzoeksgroup Nederland" with 1 trials as a collaborator, "Dutch Cancer Society" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Leiden University Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Röpcke-Zweers Ziekenhuis" are "Breast Cancer" (1 trials), "Caesarean Section" (1 trials), "Cardiovascular Disease" (1 trials), "Endometrial Cancer" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Röpcke-Zweers Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Röpcke-Zweers Ziekenhuis" are "Drug" (3 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Etripamil" (1 trials), "Implementation aids" (1 trials), "Reduced follow-up schedule" (1 trials) and "Revlimid (lenalidomide)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Röpcke-Zweers Ziekenhuis" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Röpcke-Zweers Ziekenhuis". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Röpcke-Zweers Ziekenhuis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Röpcke-Zweers Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".